Lung Cancer Surgery Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Lung Cancer Surgery Market Analysis
Rising air pollution and people getting affected by it are one of the prime factors responsible for the growth of the market for lung cancer surgery. As per an article by the Vital Strategies Environmental Health Division staff, 2018, while most of the 4.2 million premature deaths linked to air pollution are due to heart disease and strokes, around 1.7 million deaths are from lung cancer and other respiratory diseases globally. According to the WHO database, levels of ultra-fine particles of less than 2.5 microns are highest in India, which has 16 of the world's 30 most polluted cities. Thus, a rise in air pollution is, primarily, driving the lung cancer rate, and hence the studied market is expected to be impacted.
Lung Cancer Surgery Market Trends
This section covers the major market trends shaping the Lung Cancer Surgery Market according to our research experts:
Segmentectomy is Expected to Witness High Growth
With the growing prevalence of lung cancer and technological development, the therapy line has also been improved and people can start taking treatment from the early stage, these factors are expected to further boost the growth of the lung cancer surgery market.
Segmentectomy is a common surgical treatment that can be an option to treat non-small cell lung cancer (NSCLC). It is mostly recommended over lobectomy if the patient already has a highly reduced lung reserve. Although lung segmentectomy has always been popular for resection of supportive lesions and nonmalignant masses, most of the time it is recommended for very early lung cancer.
The growing popularity of this technique is because of better outcomes, less pain, and shorter recovery than traditional surgical techniques. Segmentectomy procedure has a good success rate for removing localized tumors and cancers with higher survival rates, with the retention of organ functions up to a certain degree and these advantages are anticipated to fuel the studied market growth.
However, there are some risks associated with segmentectomy arising from general anesthesia, which raises the chances of excessive bleeding, blood clot formation, pneumonia, and infection of the surgical wound.
North America is Expected to Dominate the Market
As per the American Cancer Society's estimation, the new cases of lung cancer in the United States for 2018 were around 234,030, and about 154,050 deaths were expected due to lung cancer. In the United States, lung cancer survival has been improved and the incidence of localized lung cancer has increased.
According to the American Lung Association (2018), approximately 541,000 Americans living today have been diagnosed with lung cancer at some point in their lives. The majority of lung cancer patients have been diagnosed within the last five years. Each year, around tens of thousands of people, are cured of non-small cell lung cancer (NSCLC) in the United States. Lung cancer is mostly a disease of the elderly. This indicates the burden of lung cancer in this country and this is resulting in the growth of the market studied as there is a high demand for cancer treatment in the United States.
Lung Cancer Surgery Industry Overview
The lung cancer surgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products at cheaper prices.
Lung Cancer Surgery Market Leaders
-
Accuray Incorporated
-
GE Healthcare
-
Johnson and Johnson
-
Olympus Corporation
-
Siemens Healthineers AG
*Disclaimer: Major Players sorted in no particular order
Lung Cancer Surgery Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Burden of Lung Cancer
-
4.2.2 Technological Advancements in the Field of Minimally Invasive Surgeries
-
4.2.3 Rise in the Level of Air Pollution
-
-
4.3 Market Restraints
-
4.3.1 Effective Alternative Treatment
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 Thoracotomy
-
5.1.1.1 Lobectomy
-
5.1.1.2 Sleeve Resection
-
5.1.1.3 Segmentectomy
-
5.1.1.4 Pneumonectomy
-
-
5.1.2 Minimally Invasive Surgeries
-
-
5.2 By Product
-
5.2.1 Surgical Devices
-
5.2.2 Monitoring Devices
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Accuray Incorporated
-
6.1.2 GE Healthcare
-
6.1.3 Johnson & Johnson
-
6.1.4 Olympus Corporation
-
6.1.5 Richard Wolf GmbH
-
6.1.6 Siemens Healthineers AG
-
6.1.7 AngioDynamics Inc.
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Lung Cancer Surgery Industry Segmentation
Lung cancer is the lethal lung tumor portrayed by the uncontrolled growth of cells in the lung tissues. The interpretation of lung cancer is confirmed by biopsy, which is carried out using bronchoscopy or CT-guidance. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumor and its position within the lung.
| By Type | ||||||
| ||||||
| Minimally Invasive Surgeries |
| By Product | |
| Surgical Devices | |
| Monitoring Devices |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Lung Cancer Surgery Market Research FAQs
What is the current Lung Cancer Surgery Market size?
The Lung Cancer Surgery Market is projected to register a CAGR of 7% during the forecast period (2024-2029)
Who are the key players in Lung Cancer Surgery Market?
Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation and Siemens Healthineers AG are the major companies operating in the Lung Cancer Surgery Market.
Which is the fastest growing region in Lung Cancer Surgery Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Lung Cancer Surgery Market?
In 2024, the North America accounts for the largest market share in Lung Cancer Surgery Market.
What years does this Lung Cancer Surgery Market cover?
The report covers the Lung Cancer Surgery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Lung Cancer Surgery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Lung Cancer Surgery Industry Report
Statistics for the 2024 Lung Cancer Surgery market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Lung Cancer Surgery analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Lung Cancer Surgery Report Snapshots
